Table 3.
Non‐COVID patient | COVID patient (known or suspected) | |
---|---|---|
Triage | ||
Acuity or indications | Postpone elective† | See footnote‡ |
Screening | Symptoms§, sick contacts§, pre‐procedure vitals | Not applicable |
Procedure | ||
Ideal setting | Negative pressure room | Negative pressure room |
Staff | Limit personnel | Essential personnel only |
Mask for patient | Slotted mask if transnasal or transoral approach without advanced airway | Yes (if not intubated) |
PPE | ||
Mask |
N95 or FFP3 if significant community prevalence Consider daily re‐used N95 or FFP3 if low supply |
PAPR (superior protection), N95 or FFP3 |
Eyes | Eye protection; full face shield if re‐using N95/FFP3 | Full face shield |
Other | Gown, gloves, cap | Gown, gloves, cap |
Anaesthesia |
Avoid atomized or nebulized lidocaine Sedation to minimize cough Consider paralysis to minimize cough in general anaesthesia |
Avoid atomized or nebulized lidocaine Sedation to minimize cough Consider paralysis to minimize cough in general anaesthesia |
Equipment | No consensus/recommendations | Disposable if available |
Approach | Avoid rigid bronchoscopy¶ | Avoid rigid bronchoscopy¶; minimize flexible scope in/out |
Ventilation | Closed‐circuit ventilation if advanced airway; avoid jet | Closed‐circuit ventilation if advanced airway; avoid jet |
Post‐procedure | ||
Scope disinfection | No consensus/recommendations | Standard high level |
Room disinfection | No consensus/recommendations |
Consider air circulation time per local air controls Consider sterilizing surfaces |
Specific indications considered elective by AABIP: mild airway stenosis, mucus clearance, suspected sarcoidosis without indication for immediate treatment, chronic interstitial lung disease, suspected Mycobacterium avium‐intracellulare, chronic cough, tracheobronchomalacia evaluation, bronchial thermoplasty and bronchoscopic lung volume reduction.
Possible indications: inconclusive non‐invasive COVID‐19 testing2, 3, 4, 5; concern for an alternate aetiology of respiratory disease which would change management2, 3, 4, 5 (especially in immunocompromised4); suspicion of superinfection4, 5; lobar or entire lung atelectasis concerning for mucus plugging,4 facilitate tracheostomy,4 life‐saving or emergent intervention (significant haemoptysis, severe central airway obstruction or stenosis, foreign body).2, 3, 4, 5
Consider phone screening 1–2 days in advance.
Unless unavoidable in the clinical circumstance.
AABIP, American Association for Bronchology and Interventional Pulmonology; COVID‐19, coronavirus disease 2019; PAPR, powered air‐purifying respirator; PPE, personal protective equipment.